• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对明胶酶具有选择性的强效慢结合抑制剂的设计、合成与表征。

Design, synthesis, and characterization of potent, slow-binding inhibitors that are selective for gelatinases.

作者信息

Bernardo M Margarida, Brown Stephen, Li Zhi-Hong, Fridman Rafael, Mobashery Shahriar

机构信息

Department of Pathology, Wayne State University, Detroit, Michigan 48201, USA.

出版信息

J Biol Chem. 2002 Mar 29;277(13):11201-7. doi: 10.1074/jbc.M111021200. Epub 2002 Jan 14.

DOI:10.1074/jbc.M111021200
PMID:11790786
Abstract

Gelatinases have been shown to play a key role in angiogenesis and tumor metastasis. Small molecular weight synthetic inhibitors for these enzymes are highly sought for potential use as anti-metastatic agents. Virtually all of the known inhibitors of matrix metalloproteinases (MMPs) are broad spectrum. We report herein the synthesis and kinetic characterization of two compounds, 4-(4-phenoxyphenylsulfonyl)butane-1,2-dithiol (compound 1) and 5-(4-phenoxyphenylsulfonyl)pentane-1,2-dithiol (compound 2), that are potent and selective gelatinase inhibitors. These compounds are slow, tight-binding inhibitors of gelatinases (MMP-2 and MMP-9) with K(i) values in the nanomolar range. In contrast, competitive inhibition of the catalytic domain of membrane-type 1 metalloproteinase (MMP-14(cat)) with comparable K(i) values (K(i) approximately 200 nm) was observed. Binding to stromelysin (MMP-3) was substantially weaker, with K(i) values in the micromolar range (K(i) approximately 10 microm). No binding to matrilysin (MMP-7) and collagenase 1 (MMP-1) was detected at inhibitor concentrations up to 60 microm. We have previously shown that synthetic MMP inhibitors work synergistically with TIMP-2 in the promotion of pro-MMP-2 activation by MT1-MMP in a process that depends on the affinity of the inhibitor toward MT1-MMP. It is shown herein that the dithiols are significantly less efficient (>100-fold) than marimastat, a broad-spectrum MMP inhibitor, in enhancing pro-MMP-2 activation in cells infected to express MT1-MMP, consistent with the lower affinity of the dithiols toward MT1-MMP. Thus, in contrast to broad-spectrum MMP inhibitors, the dithiols are less likely to promote MT1-MMP-dependent pro-MMP-2 activation in the presence of TIMP-2, while maintaining their ability to inhibit active MMP-2 effectively.

摘要

明胶酶已被证明在血管生成和肿瘤转移中起关键作用。人们一直在寻找这些酶的小分子合成抑制剂,以用作潜在的抗转移剂。几乎所有已知的基质金属蛋白酶(MMP)抑制剂都是广谱的。我们在此报告两种化合物4-(4-苯氧基苯基磺酰基)丁烷-1,2-二硫醇(化合物1)和5-(4-苯氧基苯基磺酰基)戊烷-1,2-二硫醇(化合物2)的合成及动力学特征,它们是强效且选择性的明胶酶抑制剂。这些化合物是明胶酶(MMP-2和MMP-9)的缓慢、紧密结合抑制剂,其抑制常数(K(i))值在纳摩尔范围内。相比之下,观察到对膜型1金属蛋白酶(MMP-14(cat))催化结构域具有竞争性抑制作用,其K(i)值相当(K(i)约为200 nM)。与基质溶解素(MMP-3)的结合则弱得多,K(i)值在微摩尔范围内(K(i)约为10 μM)。在抑制剂浓度高达60 μM时,未检测到与基质溶素(MMP-7)和胶原酶1(MMP-1)的结合。我们之前已经表明,合成的MMP抑制剂在MT1-MMP促进前MMP-2激活的过程中与TIMP-2协同作用,该过程取决于抑制剂对MT1-MMP的亲和力。本文表明,在感染表达MT1-MMP的细胞中,二硫醇在增强前MMP-2激活方面的效率明显低于广谱MMP抑制剂马立马司他(>100倍),这与二硫醇对MT1-MMP的较低亲和力一致。因此,与广谱MMP抑制剂不同,二硫醇在存在TIMP-2的情况下促进MT1-MMP依赖性前MMP-2激活的可能性较小,同时保持其有效抑制活性MMP-2的能力。

相似文献

1
Design, synthesis, and characterization of potent, slow-binding inhibitors that are selective for gelatinases.对明胶酶具有选择性的强效慢结合抑制剂的设计、合成与表征。
J Biol Chem. 2002 Mar 29;277(13):11201-7. doi: 10.1074/jbc.M111021200. Epub 2002 Jan 14.
2
Synthesis, kinetic characterization and metabolism of diastereomeric 2-(1-(4-phenoxyphenylsulfonyl)ethyl)thiiranes as potent gelatinase and MT1-MMP inhibitors.作为潜在的明胶酶和 MT1-MMP 抑制剂,(±)-2-(1-(4-苯氧基苯磺酰基)乙基)硫代吗啉的立体选择性合成、动力学特征和代谢研究。
Chem Biol Drug Des. 2009 Dec;74(6):535-46. doi: 10.1111/j.1747-0285.2009.00898.x. Epub 2009 Oct 12.
3
Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.金属蛋白酶组织抑制剂-4通过有效抑制膜型1-基质金属蛋白酶来抑制而非支持明胶酶A的激活。
Cancer Res. 2001 May 1;61(9):3610-8.
4
The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A.膜型1基质金属蛋白酶的前肽结构域对于金属蛋白酶组织抑制剂的结合以及前明胶酶A的激活是必需的。
J Biol Chem. 1998 Dec 25;273(52):34745-52. doi: 10.1074/jbc.273.52.34745.
5
Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).金属蛋白酶组织抑制剂2(TIMP-2)的序列基序决定了前明胶酶A(proMMP-2)与膜型金属蛋白酶1(MT1-MMP)的结合及激活。
Biochem J. 2003 Jun 15;372(Pt 3):799-809. doi: 10.1042/BJ20021573.
6
Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation.活性(57 kDa)膜型1基质金属蛋白酶(MT1-MMP)与金属蛋白酶组织抑制剂(TIMP)-2的结合可调节MT1-MMP的加工及前MMP-2的激活。
J Biol Chem. 2000 Apr 21;275(16):12080-9. doi: 10.1074/jbc.275.16.12080.
7
Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2).人基质金属蛋白酶-2(MMP-2)强效慢结合抑制的结构基础
J Biol Chem. 2003 Jul 18;278(29):27009-15. doi: 10.1074/jbc.M301139200. Epub 2003 Apr 4.
8
Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.子宫内膜癌中活性明胶酶的存在以及基质金属蛋白酶表达与肿瘤分级增加和侵袭的相关性。
Cancer. 2002 Mar 1;94(5):1466-75. doi: 10.1002/cncr.10355.
9
Potent mechanism-based inhibitors for matrix metalloproteinases.基于机制的强效基质金属蛋白酶抑制剂。
J Biol Chem. 2005 Oct 7;280(40):33992-4002. doi: 10.1074/jbc.M504303200. Epub 2005 Jul 26.
10
N-substituted homopiperazine barbiturates as gelatinase inhibitors.N-取代的同哌嗪类巴比妥酸盐作为明胶酶抑制剂。
Bioorg Med Chem. 2011 Aug 15;19(16):4985-99. doi: 10.1016/j.bmc.2011.06.055. Epub 2011 Jun 25.

引用本文的文献

1
Glycocalyx disruption, endothelial dysfunction and vascular remodeling as underlying mechanisms and treatment targets of chronic venous disease.糖萼破坏、内皮功能障碍和血管重塑作为慢性静脉疾病的潜在机制和治疗靶点。
Int Angiol. 2024 Dec;43(6):563-590. doi: 10.23736/S0392-9590.24.05339-2.
2
New Derivatives of Hydroxybutanamide: Preparation, MMP Inhibition, Cytotoxicity, and Antitumor Activity.羟基丁酰胺的新衍生物:制备、MMP 抑制、细胞毒性和抗肿瘤活性。
Int J Mol Sci. 2023 Nov 15;24(22):16360. doi: 10.3390/ijms242216360.
3
One pot synthesis of two cobalt(iii) Schiff base complexes with chelating pyridyltetrazolate and exploration of their bio-relevant catalytic activities.
一锅法合成两种含螯合吡啶四唑的钴(III)席夫碱配合物及其生物相关催化活性探究
RSC Adv. 2018 Aug 7;8(49):28216-28237. doi: 10.1039/c8ra03035a. eCollection 2018 Aug 2.
4
Identification of Slow-Binding Inhibitors of the BoNT/A Protease.肉毒杆菌神经毒素A蛋白酶慢结合抑制剂的鉴定
ACS Med Chem Lett. 2022 Mar 8;13(4):742-747. doi: 10.1021/acsmedchemlett.2c00028. eCollection 2022 Apr 14.
5
Mechanisms of Lower Extremity Vein Dysfunction in Chronic Venous Disease and Implications in Management of Varicose Veins.慢性静脉疾病中下肢静脉功能障碍的机制及其对静脉曲张治疗的意义
Vessel Plus. 2021;5. doi: 10.20517/2574-1209.2021.16. Epub 2021 May 29.
6
Irreversible inhibition of BoNT/A protease: proximity-driven reactivity contingent upon a bifunctional approach.肉毒杆菌神经毒素A蛋白酶的不可逆抑制:基于双功能方法的邻近驱动反应性
RSC Med Chem. 2021 May 19;12(6):960-969. doi: 10.1039/d1md00089f. eCollection 2021 Jun 23.
7
Challenges in Matrix Metalloproteinases Inhibition.基质金属蛋白酶抑制的挑战。
Biomolecules. 2020 May 5;10(5):717. doi: 10.3390/biom10050717.
8
Examination of sulfonamide-based inhibitors of MMP3 using the conditioned media of invasive glioma cells.使用侵袭性神经胶质瘤细胞的条件培养基检测基质金属蛋白酶 3 的磺胺类抑制剂。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):672-681. doi: 10.1080/14756366.2020.1715387.
9
Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.基质金属蛋白酶、血管重塑与血管疾病
Adv Pharmacol. 2018;81:241-330. doi: 10.1016/bs.apha.2017.08.002. Epub 2017 Sep 19.
10
Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.基质金属蛋白酶抑制剂作为无节制组织重塑和病理紊乱中的研究及治疗工具
Prog Mol Biol Transl Sci. 2017;148:355-420. doi: 10.1016/bs.pmbts.2017.04.003. Epub 2017 May 10.